Welcome to
Schurgers Lab
About the Schurgers Lab
In the Schurgers group, we are dedicated to unraveling cellular and molecular mechanisms driving cardiovascular remodelling and its impact on cardiovascular health and ageing. Our team focuses on understanding how ageing influences diseases such as atherosclerosis, arteriosclerosis, aneurysm formation, rupture and dissection and the role of monogenetic diseases leading to vasculopathies and cardiomyopathies. By bridging fundamental and clinical science we work towards translational applications, aiming to develop innovative solutions for complex medical challenges.
Publication highlights
High-impact publication
Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification: A Randomized Clinical Trial.
Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signalling.
miR-24-3p secreted as extracellular vesicle cargo by cardiomyocytes inhibits fibrosis in human cardiac microtissues.
Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol.
Development of the BioHybrid Assay: Combining Primary Human Vascular Smooth Muscle Cells and Blood to Measure Vascular Calcification Propensity.